Conversely, ERK/JNK MAPK modules are activated by Tpl2, CXCR4 signals are amplified, and ccRCC metastasis is potentiated (Lee et al., 2013). The gene discussed is CXCR4; the disease is nonpapillary renal cell carcinoma.